Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Tennessee Voters Weigh in on Rx Drug Costs


 

Nearly three-quarters of Tennessee voters feel the cost of prescription drugs is "unreasonable" and about half are not satisfied with how President Trump and members of both parties of Congress are handling the issue, according to a new poll released today by the West Health Institute, a nonpartisan, nonprofit healthcare research organization.

The survey of 750 registered Tennessee voters found that 85 percent are concerned over the high cost of prescription drugs, with more than a third (36 percent) saying they have not filled or taken drugs as prescribed because of its cost in the last year, which 74 percent find "unreasonable."

Voters are mostly disapproving of the way the president and Republicans and Democrats in Congress are handling the high cost of prescription drugs, which is likely to be a key campaign issue in the run up to the midterm elections: 46 percent of respondents disapprove of the way President Trump is handling the issue, while 52 percent disapprove of the way congressional Republicans are handling it and 48 percent disapprove of the way congressional Democrats are handling it. The survey found 70 percent of all Tennessee voters, regardless of party affiliation, believe reining in high prescription drug costs should be a top priority for candidates running for Congress.

"In this polarized political environment, rarely does an issue cut across party lines so strongly. This poll shows all Tennesseans are fed up with the high cost of drugs and will reward candidates who support common-sense solutions like allowing Medicare to directly negotiate prices with drug companies," said Shelley Lyford, president and CEO of the West Health Institute. "Voters have told their candidates what they want them to do. Now it's up to the candidates to make it a priority issue."

The survey found the cost of healthcare is the single most important issue facing the country for 59 percent of Tennessee voters-- even more important than jobs and the economy (46 percent), immigration (31 percent) and national security concerns (30 percent).

When asked about possible ways to reduce drug costs, in particular, 87 percent support allowing Medicare to negotiate directly with drug companies and 73 percent said they would be more likely to vote for a candidate who supports this approach.

Meanwhile, 85 percent said they want President Trump to take steps to clear the way for Medicare to negotiate directly. The president previously supported the idea but did not include it as part of his "Blueprint to Lower Drug Prices" released in May 2018.

Under current law, the federal government is explicitly prohibited from negotiating directly with pharmaceutical companies to lower drug prices for Medicare. According to the Centers for Medicare & Medicaid Services, national health spending was $3.3 trillion in 2016, with $328.6 billion going toward prescription drugs.

A large majority of voters (85 percent) also support requiring drug companies to release information to the public on how they set their prices and 40 percent support requiring drug companies to set the price of a drug based on how well it works for patients.

"New common sense drug pricing policies are desperately needed before runaway costs cripple our economy and adversely affect millions of Americans," said Tim Lash, chief strategy officer and executive vice president of the West Health Institute. "Our survey shows a majority of Tennesseans are ready to make their voices heard on election day, as their health and well-being is at stake."

To view the full report, visit: https://www.westhealth.org/resource/opinion-poll-tennessee-voters-want-action-on-the-high-price-of-prescription-drugs/

 
Share:

Related Articles:


Recent Articles

Competition Levels Drop in Health Insurance Markets across 25 States

Read More

Lifepoint Health And Rcch Healthcare Partners Announce Completion Of Merger

Read More

Cancer Care on the Cutting Edge

Nashville physician-scientists are helping lead the way in advancing cancer care.

Read More

The Evolution of Senior Living

The senior living industry is undergoing a makeover as baby boomers shift focus from medical-directed care to hospitality-driven services.

Read More

When Basic Science Becomes a Breakthrough

Noted immunologists joined forces at the recent International Cancer Immunotherapy Conference to discuss the importance of fostering and funding basic science.

Read More

Dr. Meredith McKean Brings New Hope, More Options for Melanoma Patients

Oncologist Meredith McKean, MD, MPH, overseeing Sarah Cannon's Melanoma Research Program

Read More

ONcology Rounds

News of note in cancer research, treatment and partnerships.

Read More

Ascension Saint Thomas Opens Cancer Center

Ascension Saint Thomas recently celebrated the grand opening of their comprehensive new cancer center on the Midtown campus.

Read More

NMGMA 10 Minute Takeaway

Medicare Part B representative from Palmetto GBA offered updates and resources to navigate compliance.

Read More

Improving Quality, Lowering Cost of Care for Seniors

Five years into the Medicare Shared Savings Program, more and more ACOs are beginning to demonstrate the ability to improve quality while lowering costs.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: